Contribution of Biologic Response Modifiers to the Risk of Coccidioidomycosis Severity.
Donovan FM, Ramadan FA, Lim JR, Buchfuhrer JE, Khan RN, DeQuillfeldt NP, Davis NM, Kaveti A, De Shadarevian M, Bedrick EJ, Galgiani JN.
Donovan FM, et al.
Open Forum Infect Dis. 2022 Jan 27;9(3):ofac032. doi: 10.1093/ofid/ofac032. eCollection 2022 Mar.
Open Forum Infect Dis. 2022.
PMID: 35169593
Free PMC article.